Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, Seres Therapeutics Inc’s stock clocked out at $0.78, up 0.13% from its previous closing price of $0.78. In other words, the price has increased by $0.13 from its previous closing price. On the day, 0.75 million shares were traded. MCRB stock price reached its highest trading level at $0.7915 during the session, while it also had its lowest trading level at $0.77.
Ratios:
To gain a deeper understanding of MCRB’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.12 and its Current Ratio is at 1.12. In the meantime, Its Debt-to-Equity ratio is 3.91 whereas as Long-Term Debt/Eq ratio is at 3.56.
On April 21, 2023, JP Morgan started tracking the stock assigning a Neutral rating and target price of $7.JP Morgan initiated its Neutral rating on April 21, 2023, with a $7 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 18 ’24 when DesRosier Thomas sold 878 shares for $0.54 per share. The transaction valued at 475 led to the insider holds 135,192 shares of the business.
von Moltke Lisa sold 977 shares of MCRB for $528 on Nov 18 ’24. The insider now owns 32,415 shares after completing the transaction at $0.54 per share. On Nov 18 ’24, another insider, Shaff Eric D., who serves as the CEO and President of the company, sold 2,505 shares for $0.54 each. As a result, the insider received 1,355 and left with 170,389 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MCRB now has a Market Capitalization of 133517120 and an Enterprise Value of 132390424. For the stock, the TTM Price-to-Sale (P/S) ratio is 2225.33 while its Price-to-Book (P/B) ratio in mrq is 5.56. Its current Enterprise Value per Revenue stands at 1.048 whereas that against EBITDA is -3.627.
Stock Price History:
The Beta on a monthly basis for MCRB is 2.16, which has changed by -0.32 over the last 52 weeks, in comparison to a change of 0.19995654 over the same period for the S&P500. Over the past 52 weeks, MCRB has reached a high of $1.53, while it has fallen to a 52-week low of $0.54. The 50-Day Moving Average of the stock is -8.74%, while the 200-Day Moving Average is calculated to be -12.72%.
Shares Statistics:
It appears that MCRB traded 2.65M shares on average per day over the past three months and 952990 shares per day over the past ten days. A total of 170.20M shares are outstanding, with a floating share count of 124.81M. Insiders hold about 26.90% of the company’s shares, while institutions hold 23.95% stake in the company. Shares short for MCRB as of 1736899200 were 20261193 with a Short Ratio of 7.66, compared to 1734048000 on 19613483. Therefore, it implies a Short% of Shares Outstanding of 20261193 and a Short% of Float of 15.879999999999999.
